HIV-1 Alters Nuclear Pores to Enable Infection
HIV-1 Signalling Remodels Nuclear Pores to Licence Infection in Resting T Cells Human Immunodeficiency Virus type 1 (HIV-1) continues to challenge the scientific and medical...
HIV-1 Signalling Remodels Nuclear Pores to Licence Infection in Resting T Cells Human Immunodeficiency Virus type 1 (HIV-1) continues to challenge the scientific and medical...
In a groundbreaking new study that could reshape the landscape of cancer immunotherapy, researchers have discovered a novel mechanism to enhance T-cell activation by targeting...
A Comprehensive Examination of Aluminium Adjuvants in Vaccines Reveals No Causal Link to Serious Health Conditions In an extensive systematic review published today in The...
In a groundbreaking clinical trial that may transform the management of peanut allergies among young children, researchers from Karolinska Institutet have demonstrated the safety and...
Sophia Antipolis, France – May 7, 2026. In a landmark report published today in the European Heart Journal, leading cardiology experts from across Europe have...
A groundbreaking study led by researchers at the University of Cambridge has revealed a significant shift in mental health clinicians’ attitudes toward understanding anxiety disorders....
In a groundbreaking study published in npj Parkinson’s Disease, a team of researchers led by Sun, X., An, Z., and Wang, S. has unveiled compelling...
In an era where the SARS-CoV-2 virus continuously evolves, understanding the nuances of its spike protein’s conformation is pivotal for staying ahead in therapeutic development....
In a groundbreaking new study published in npj Parkinson’s Disease, researchers have unveiled a compelling connection between allergic diseases and the risk of Parkinson’s disease...
A groundbreaking study published in Nature underlines a transformative insight into the human proteome, revealing a landscape enriched by microproteins and peptideins originating from non-canonical...
In a groundbreaking clinical milestone, the novel targeted RAS inhibitor daraxonrasib has demonstrated both safety and promising efficacy in a phase 1/2 trial involving patients...
The upcoming ASCO 2026 Annual Meeting, scheduled to take place in Chicago from May 29 to June 2, promises to be a pivotal event in...
In a groundbreaking development that promises to reshape the therapeutic landscape for colorectal cancer, researchers at the Icahn School of Medicine at Mount Sinai, in...
Electronic nematicity, a fascinating phase found in a variety of crystalline solids, has been thrust into the spotlight of condensed matter physics for its crucial...
In an ambitious convergence of cutting-edge research and practical engineering, the 23rd Carbon Research International Forum, hosted online on April 24, 2026, spotlighted the transformative...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.